AI-generated summary
The authors tested immuno-targeted gold-iron oxide hybrid nanoparticles in mice with colorectal cancer xenograft tumors. They report that the particles accumulated in antigen-expressing tumors, that near-infrared laser treatment at 808 nm was associated with damage to over 65% of those tumor cells, and that the particles worked as MRI contrast agents. The study was conducted in a xenograft tumor model.
- Who or what was studied
- Mice with SW1222 xenograft colorectal cancer tumors
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract describes only a xenograft tumor model and does not report a human sample or clinical outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808nm
- Power
- 5W
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Collagen. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.